chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 01-APR-2014, the patient was vaccinated with ZOSTAVAX (dose strength and route was not reported) (lot # J01182 and expiry date: 16-DEC-2014) w01182hich was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting ZOSTAVAX, nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for ZOSTAVAX. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 16-SEP-2013, the patient was vaccinated with ZOSTAVAX (dose strength and route was not reported) (lot # J001700 and expiry date: 08-MAY-2014) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting ZOSTAVAX, nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for ZOSTAVAX. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 15-OCT-2013, the patient was vaccinated with ZOSTAVAX (dose strength and route was not reported) (lot # J001700 and expiry date: 08-MAY-2014) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting ZOSTAVAX, nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for ZOSTAVAX. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 16-JUL-2013, the patient was vaccinated with ZOSTAVAX (dose strength and route was not reported) (lot # J000495 and expiry date: 14-APR-2014) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting ZOSTAVAX, nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for ZOSTAVAX. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 04-APR-2014, the patient was vaccinated with VARIVAX (Merck) (dose strength and route was not reported) (lot # J007954 and expiry date: 27-JUN-2015) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting VARIVAX (Merck), nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for VARIVAX (Merck). This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 28-JUL-2014, the patient was vaccinated with PROQUAD (Merck) (dose strength and route was not reported) (lot # J014235 and expiry date: 07-MAY-2015) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting PROQUAD (Merck), nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for PROQUAD (Merck). This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HEPA, MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a healthcare worker referring to a patient of unknown age and gender. On an unknown date, the patient was vaccinated with a dose of VAQTA and M-M-R II (strength, lot number, expiry date, route and dose were not reported for both vaccines), which were improperly stored by exposed to 31.5F for 29 hours. No adverse effects were reported. This is one of several reports received from the same reporter. (Linked to 1501USA012473, 1501USA012474, 1501USA012475, 1501USA012476). Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 27-FEB-2014, the patient was vaccinated with ZOSTAVAX (dose strength and route was not reported) (lot # J008433 and expiry date: 11-OCT-2014) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting ZOSTAVAX, nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for ZOSTAVAX. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 03-DEC-2013, the patient was vaccinated with VARIVAX (Merck) (dose strength and route was not reported) (lot # H018455 and expiry date: 09-OCT-2014) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting VARIVAX (Merck), nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for VARIVAX (Merck). This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 02-DEC-2014, the patient was vaccinated with ZOSTAVAX (dose strength and route was not reported) (lot # K011004 and expiry date: 07-NOV-2015) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting ZOSTAVAX, nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for ZOSTAVAX. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 02-DEC-2014, the patient was vaccinated with ZOSTAVAX (dose strength and route was not reported) (lot # K0011004 and expiry date: 07-NOV-2015) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting ZOSTAVAX, nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for ZOSTAVAX. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 03-DEC-2013, the patient was vaccinated with ZOSTAVAX (dose strength and route was not reported) (lot # J008433 and expiry date: 11-OCT-2014) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting ZOSTAVAX, nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for ZOSTAVAX. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 26-NOV-2013, the patient was vaccinated with ZOSTAVAX (dose strength and route was not reported) (lot # J0006831 and expiry date: 14-SEP-2014) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting ZOSTAVAX, nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for ZOSTAVAX. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 25-NOV-2014, the patient was vaccinated with ZOSTAVAX (dose strength and was not reported) (lot # K011004 and expiry date: 07-NOV-2015) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting ZOSTAVAX, nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for ZOSTAVAX. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 09-OCT-2014, the patient was vaccinated with ZOSTAVAX (dose strength and route was not reported) (lot # K000456 and expiry date: 15-DEC-2014) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting ZOSTAVAX, nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for ZOSTAVAX. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 28-MAR-2014, the patient was vaccinated with ZOSTAVAX (dose strength and route was not reported) (lot # J011828 and expiry date: 26-DEC-2014, reported as 16-DEC-2014) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting ZOSTAVAX, nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for ZOSTAVAX. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 13-OCT-2014, the patient was vaccinated with ZOSTAVAX (dose strength and route was not reported) (lot # K00456 and expiry date: 15-DEC-2014) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting ZOSTAVAX, nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for ZOSTAVAX. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 29-MAY-2014, the patient was vaccinated with PROQUAD (Merck) (dose strength and route was not reported) (lot # J002302 and expiry date: 22-AUG-2014) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting PROQUAD (Merck), nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for PROQUAD (Merck). This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Swelling
Clinical narrative: This spontaneous report has been received from a pharmacist refers to an unspecified number of patients of unknown age and gender. On unknown dates the patients were vaccinated with ZOSTAVAX (dose, frequency, route and lot# were not reported). The pharmacist reported that the patients complained swelling in the past. The swelling was reported as resolved on its own for all patients. The causality was not reported. Additional information has been requested.
Age: 44.0
Sex: F
Vaccine: MMR
Symptoms: Deafness, Dizziness, Dysarthria, Hypoaesthesia, Pyrexia
Clinical narrative: As patient left parking lot, started experiencing fever, loss of hearing. Numbness in hands, slurred speech. Pulled over and felt faint. Felt better in about 30 minutes. Symptom have all disappeared.
Age: 63.0
Sex: M
Vaccine: PPV
Symptoms: Pain, Pain in extremity, Tenderness
Clinical narrative: Pt called day after administration of vaccine with pain from elbow to shoulder - painful to move or touch. Followed up 1/31/15 - pt symptoms resolving and pain decreasing.
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Feeling hot, Immediate post-injection reaction, Injection site pain, Pain
Clinical narrative: Pt. said the injection started hurting immediately and within the hour her arm was very swollen, blood red, throbbing, hot/feverish. It took 2 wks for symptoms to resolve.
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Peripheral swelling, Pyrexia
Clinical narrative: Pt. said the injection started hurting immediately and within the hour her arm was very swollen, blood red, throbbing, hot/feverish. It took 2 wks for symptoms to resolve.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 15-JAN-2014, the patient was vaccinated with ZOSTAVAX (dose strength and route was not reported) (lot # J008433 and expiry date: 11-OCT-2014) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting ZOSTAVAX, nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for ZOSTAVAX. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 25-JUN-2013, the patient was vaccinated with ZOSTAVAX (dose strength and route was not reported) (lot # J00495 and expiry date: 14-APR-2014) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting ZOSTAVAX, nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for ZOSTAVAX. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 22-NOV-2013, the patient was vaccinated with VARIVAX (dose strength and route was not reported) (lot# H018455 and expiry date: 09-OCT-2014) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting VARIVAX (Merck), nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for VARIVAX (Merck). This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 04-JUN-2013, the patient was vaccinated with ZOSTAVAX (dose strength and route was not reported) (lot # J000495 and expiry date: 14-APR-2014) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting ZOSTAVAX, nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for ZOSTAVAX. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 12-NOV-2013, the patient was vaccinated with ZOSTAVAX (dose strength and route was not reported) (lot # J000495 and expiry date: 14-APR-2014) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting ZOSTAVAX, nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for ZOSTAVAX. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 12-NOV-2013, the patient was vaccinated with VARIVAX (Merck) (dose strength and route was not reported) (lot # J002618 and expiry date: 01-MAR-2015) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting VARIVAX (Merck), nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for VARIVAX (Merck). This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 15-OCT-2014, the patient was vaccinated with VARIVAX (Merck) (dose strength and route was not reported) (lot # J004159 and expiry date: 08-APR-2015) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting VARIVAX (Merck), nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for VARIVAX (Merck). This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 14-NOV-2014, the patient was vaccinated with ZOSTAVAX (dose strength and route was not reported) (lot # K011004 and expiry date: 07-NOV-2015) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting ZOSTAVAX, nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for ZOSTAVAX. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 06-JUN-2014, the patient was vaccinated with PROQUAD (Merck) (dose strength and route was not reported) (lot # J002302 and expiry date: 22-AUG-2014) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting PROQUAD (Merck), nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for PROQUAD (Merck). This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 15-AUG-2014, the patient was vaccinated with PROQUAD (Merck) (dose strength and route was not reported) (lot # J014235 and expiry date: 07-MAY-2015) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting PROQUAD (Merck), nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for PROQUAD (Merck). This is one of the several reports from the same reporter. Additional information has been requested.
Age: 0.25
Sex: F
Vaccine: DTAP
Symptoms: Autism, Bronchiolitis, Crying
Clinical narrative: My daughter cried uncontrollably for 12 hours after she received the Dtap. Two days later, she came down with bronchiolitis. Within a year she started exhibiting signs of autism.
Age: 11.0
Sex: F
Vaccine: HPV4
Symptoms: Electroencephalogram normal, Seizure, Unresponsive to stimuli
Clinical narrative: Seizure during sleep.  Unresponsive for several minutes following.  Never experienced seizures before this episode.
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site rash, Injection site warmth
Clinical narrative: Patient came back to the pharmacy a couple of days later to report a "rash" on her arm where the injection took place.  She said it was red and hot.  It appeard to be an injection site reaction very common with a live vaccine.
Age: 53.0
Sex: F
Vaccine: FLU3
Symptoms: Arthralgia, Dry skin, Flushing, Headache, Injection site erythema
Clinical narrative: Initially left arm became extremely painful at injection site. Then within an hour it was bright red raised round in-duration approximately 4 in across. Swelling increased with the evening over the injection site, raising the deltoid area. Extreme itching began in the left axilla. Pain radiated down the left arm into the thumb. Pain radiated up the left side of the neck making it difficult to turn or move head without pain.  Headache began by evening aggravated by neck pain. By night I ached all over and joints especially. By the next morning a butterfly rash appeared across my face and then began to peel like a sunburn. By the evening of the next day my arms were flushed, dry, rashy but no peeling.  I dealt with the pain with Tylenol and Advil.  This shot is mandatory for hospital work.  I would not ever want this again. Give me the flu instead.
Age: 53.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site induration, Injection site pain, Injection site pruritus, Injection site swelling, Pain
Clinical narrative: Initially left arm became extremely painful at injection site. Then within an hour it was bright red raised round in-duration approximately 4 in across. Swelling increased with the evening over the injection site, raising the deltoid area. Extreme itching began in the left axilla. Pain radiated down the left arm into the thumb. Pain radiated up the left side of the neck making it difficult to turn or move head without pain.  Headache began by evening aggravated by neck pain. By night I ached all over and joints especially. By the next morning a butterfly rash appeared across my face and then began to peel like a sunburn. By the evening of the next day my arms were flushed, dry, rashy but no peeling.  I dealt with the pain with Tylenol and Advil.  This shot is mandatory for hospital work.  I would not ever want this again. Give me the flu instead.
Age: 53.0
Sex: F
Vaccine: FLU3
Symptoms: Pain in extremity, Rash, Skin exfoliation
Clinical narrative: Initially left arm became extremely painful at injection site. Then within an hour it was bright red raised round in-duration approximately 4 in across. Swelling increased with the evening over the injection site, raising the deltoid area. Extreme itching began in the left axilla. Pain radiated down the left arm into the thumb. Pain radiated up the left side of the neck making it difficult to turn or move head without pain.  Headache began by evening aggravated by neck pain. By night I ached all over and joints especially. By the next morning a butterfly rash appeared across my face and then began to peel like a sunburn. By the evening of the next day my arms were flushed, dry, rashy but no peeling.  I dealt with the pain with Tylenol and Advil.  This shot is mandatory for hospital work.  I would not ever want this again. Give me the flu instead.
Age: 1.92
Sex: F
Vaccine: DTAP, IPV
Symptoms: Urticaria
Clinical narrative: Child broke out in hives all over the body which lasted for 3 days. She was seen by the administering pediatrician for evaluation.
Sex: U
Vaccine: MMR
Symptoms: Expired product administered, No adverse event
Clinical narrative: Information has been received from a healthcare worker concerning an unspecified number of patients of unknown age and gender. Between 10-JAN-2015 and 26-JAN-2015, these patients were vaccinated with M-M-R II (dose, dose#, lot# and route were not reported), which was expired on 09-JAN-2015. No adverse effects were reported. Additional information is not expected because no reporter contact detail was provided.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from an office staff worker at a doctor's office via a field employee concerning unknown amount of patients who were vaccinated with improperly stored ZOSTAVAX (dose, route and lot number not provided). No adverse effect was reported at this time. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a healthcare worker referring to a patient of unknown age and gender. On 26-JAN-2015 the patient was vaccinated with one dose of improperly stored VARIVAX (Merck) (0.5 ml, subcutaneous, lot# and expire date were not reported). There was temperature stability issue and there was subsequent temperature excursions for the vaccine. No adverse effects reported. Additional information has been requested.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site reaction, Rash erythematous, Rash pruritic
Clinical narrative: Patient developed a red round rash around site about 2 inches in diameter that itches.
Age: 49.0
Sex: F
Vaccine: FLUX
Symptoms: Urticaria
Clinical narrative: Case number PHHY2013US116813 is an initial spontaneous report from health care professional via Vaccine Adverse Event Reporting System (VAERS reference number: 480333) website on 15 Oct 2013. This case refers to 49-year-old female patient. Her medical history included hypertension. Concomitant medication included ALTACE and Aspirin. She was vaccinated with influenza vaccine (unknown manufacturer, batch number: not reported, so conservatively coded as Seasonal Influenza vaccine INN) on 03 Jan 2013. On 04 Jan 2013, after the vaccination, the patient developed hives. The outcome of events was reported as condition unchanged as of 05 Jan 2013. The seriousness and causality of event was not reported.
Age: 25.0
Sex: F
Vaccine: FLUX, HPV4
Symptoms: Exposure during pregnancy, Pregnancy test urine positive
Clinical narrative: Case number PHHY2013US121096 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS, reference number: 480937) web site on 15 Oct 2013. This report refers to a 25-year-old female patient. Her medical history included allergic to oxycodone and bee stings. Her concomitant medication included ZYRTEC, MAXALT and PRILOSEC. She was vaccinated with seasonal influenza vaccine (manufacturer and batch number unknown) and first dose of GARDASIL (batch number: 0841AA, other manufacturer) intramuscularly on 16 Sep 2011. On an unspecified date, she was found to be positive for pregnancy (pregnancy test urine positive) with estimated delivery date as 11 May 2012. No other information was provided.
Sex: F
Vaccine: FLUX
Symptoms: Hypersensitivity
Clinical narrative: Case number PHHY2013US117522 is an initial spontaneous report from health care professional via Vaccine Adverse Event Reporting System (VAERS reference number: 480945) website on 15 Oct 2013. This case refers to a female patient of an unknown age. Her vaccination history included allergy to vaccines that contained egg. She was vaccinated with influenza vaccine (unknown manufacturer, batch number: not reported, so conservatively coded as Seasonal Influenza vaccine INN) on an unknown date. On an unspecified date, after the vaccination, the patient developed unspecified allergic reaction. The patient recovered from allergic reaction on an unknown date. The seriousness and causality of event was not reported.
Age: 17.0
Sex: M
Vaccine: FLUX
Symptoms: Body temperature fluctuation, Pyrexia
Clinical narrative: Case number PHHY2013US117343 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (reference number: 480947) on 15 Oct 2013: This report refers to a 17-year-old male patient. His medical history and concomitant medication was not reported. He was vaccinated with a seasonal influenza vaccine (manufacturer and batch number: unknown) in to the left arm on 07 Jan 2013. He experienced low grade fever on 08 Jan 2013 with temperature fluctuating from 99 to 100 degree Celsius. His fever was elevated to 102.8 degree C on 10 Jan 2013. Outcome was reported as condition unchanged as on 11 Jan 2013. No further information about seriousness and causality was reported.
Age: 63.0
Sex: F
Vaccine: FLUX, VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Injection site reaction
Clinical narrative: Case number PHHY2013US121191 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 480952) website on 15 Oct 2013. This report refers to a 63-year-old female patient. Her medical history and concomitant medication were not reported. She was vaccinated with seasonal influenza vaccine (manufacturer and batch number unknown) into unspecified arm on 17 Sep 2012. On the same day, she also received ZOSTAVAX (other manufacturer, batch number: 0468AA, expiry date: 04 Apr 2013) at a dose of  0.65 ml subcutaneously into left arm. She developed a local injection site reaction which described as itchy redness in the upper arm that persisted for seven days. She did not receive any treatment. She sought medical attention by phone call to healthcare professional. The event outcome was reported as recovered. No seriousness and causality was reported for the events.
Sex: F
Vaccine: FLUX
Symptoms: Allergy to vaccine
Clinical narrative: Case number PHHY2013US117351 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (reference number: 480967) on 15 Oct 2013: This report refers to a female patient of an unknown age. Her medical history and concomitant medicatino was not rpeorted. She was vaccinated with a seasonal Influenza vaccine (manufacturer and batch number: unknown) on an unknown date. On an unknown date, the patient had an allergy to Flu vaccine. The patient sought medical attention and received treatment (not specified). No further information was available. The event outcome was recovered.
Age: 6.0
Sex: F
Vaccine: FLUX
Symptoms: Erythema, Peripheral swelling, Pruritus, Skin warm
Clinical narrative: Case number PHHY2013US117379 is an initial spontaneous report from a health care professional via Vaccine Adverse Event Reporting System (VAERS reference number: 481024) website on 15 Oct 2013. This case refers to 06-year-old female patient. Her medical history included seasonal allergy. Her concomitant medications were not reported. She was vaccinated with Influenza vaccine (unknown manufacturer, batch number: not reported, so conservatively coded as Seasonal Influenza vaccine INN) in her arm on 01 Nov 2010. On 02 Nov 2010 she had arm swelling and itchy from shoulder to elbow which was not localized at site of injection. Her entire upper arm was hot, red, swollen and itchy which resolved in 4 to 5 days. The outcome of the events was reported as recovered as of 11 Jan 2013. The seriousness and causality assessment of the events was not reported.
Age: 66.0
Sex: F
Vaccine: FLUX
Symptoms: Pain, Pyrexia
Clinical narrative: Case number PHHY2013US117404 is an initial spontaneous report from a health care professional via Vaccine Adverse Event Reporting System (VAERS reference number: 481048) website on 15 Oct 2013. This case refers to 66-year-old female patient. Her medical history included penicillin allergy. Her concomitant medications were not reported. She was vaccinated with influenza vaccine (unknown manufacturer, batch number, not reported, so conservatively coded as Seasonal influenza vaccine INN) on 11 Jan 2013. On 12 Jan 2012 she had fever of 100.6 and severe body aches. The outcome of the events was reported as condition unchanged as of 12 Jan 2013. The seriousness and causality assessment of the events was not reported.
Sex: F
Vaccine: FLUX
Symptoms: Rash
Clinical narrative: Case number PHHY2013US117243 is an initial report received from vaccine adverse event reporting system (VAERS reference number: 481083). This report refers to a female patient of an unknown age. Medical history was not reported. Current condition of this patient includes penicillin allergy and erythromycin allergy. She was vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on an unspecified date. On an unknown date after vaccination she developed rash. Outcome of the event was reported as condition unchanged as of 30 Nov 2012. Seriousness and causality were not reported.
Sex: F
Vaccine: FLUX
Symptoms: Hypersensitivity
Clinical narrative: Case number PHHY2013US117390 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (reference number: 481084) on 15 Oct 2013: This report refers to a female patient of an unknown age. Her medical history included allergy to latex and concomitant medication was not reported. She was vaccinated with a seasonal influenza vaccine (manufacturer and bath number: unknown) on an unknown date. On an unknown date, she had an allergic reaction to the vaccine, years ago. She sought medical attention. The patient was not able to confirm the manufacturer of the influenza vaccine or to provide any further details. The event outcome was recovered. No further information about seriousness and causality was reported.
Sex: U
Vaccine: FLUX
Symptoms: Hypersensitivity
Clinical narrative: Case number PHHY2013US117402 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (reference number: 481088) on 15 Oct 2013: This report refers to a patient of an unknown age. Medical history and concomitant medication was not reported. This patient was vaccinated with a seasonal influenza vaccine (manufacturer and batch number: unknown) on an unknown date and had an allergic reaction to the vaccine on an unknown date. The event outcome was not reported. No further information about seriousness and causality was reported.
Sex: F
Vaccine: FLUX
Symptoms: Pruritus
Clinical narrative: Case number PHHY2013US117405 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (reference number: 481090) on 15 Oct 2013: This report refers to a female patient of an unknown age. Medical history and concomitant medication was not reported. This patient was vaccinated with a seasonal influenza vaccine (manufacturer and batch number: unknown) on an unknown date and experienced itching, on an unknown date. The event outcome was not reported. No further information about seriousness and causality was reported.
Sex: F
Vaccine: FLUX
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: Case number PHHY2013US116685 is an initial spontaneous report from health care professional via Vaccine Adverse Event Reporting System (VAERS reference number: 481092) website on 15 Oct 2013. This case refers to a female patient of an unknown age. Her medical history included chronic obstructive pulmonary disease (COPD), hypertension and codeine allergy. Concomitant medications included SPIRIVA, FLOVENT, TOPROL and hydrochlorothiazide. Her vaccination history included swelling and soreness at the injection site, following prior doses of influenza vaccine. She was vaccinated with influenza vaccine (unknown manufacturer, batch number: not reported, so conservatively coded as Seasonal Influenza vaccine INN) on an unspecified date. On an unspecified date, after the vaccinations, the patient developed swelling and soreness at the injection site. The outcome of events was not reported. The seriousness and causality of event was not reported.
Sex: M
Vaccine: FLUX
Symptoms: Hypersensitivity
Clinical narrative: Case number PHHY2013US117412 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (reference number: 481103) on 15 Oct 2013: This report refers to a male patient of an unknown age. Medical history and concomitant medication was not reported. This patient was vaccinated with a seasonal influenza vaccine (manufacturer and batch number: unknown) on an unknown date and developed an unspecified allergic reaction. The event outcome was not reported. No further information about seriousness and causality was reported.
Sex: U
Vaccine: FLUX
Symptoms: Hypersensitivity, Urticaria
Clinical narrative: Case number PHHY2013US117425 is an initial report received from vaccine adverse event reporting system (VAERS reference number: 481124). This report refers to a patient of an unknown age and gender. Medical history or concurrent conditions of the patient were not reported. He was vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on an unspecified date. On an unknown day after vaccination, the patient experienced an allergic reaction (described as hives). Outcome of the event was reported as complete recovery. Seriousness and causality were not reported.
Age: 59.0
Sex: M
Vaccine: FLUX, PPV, TDAP
Symptoms: Injection site swelling
Clinical narrative: Case number PHHY2013US117415 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (reference number: 481128) on 15 Oct 2013: This report refers to a 59-year-old male patient. Medical history and concomitant medication was not reported. He was vaccinated with a seasonal influenza vaccine (manufacturer and batch number: unknown) along with PNEUMOVAX (batch number: H010515) and a tetanus, diptheria and acellular pertussis (other manufacturer, batch number: Unknown) on an undetermined date. After vaccinations, the patient developed swelling at the injection site. The event outcome was not reported. No further information about seriousness and causality was reported.
Age: 29.0
Sex: F
Vaccine: FLUX, TDAP, VARCEL
Symptoms: Exposure during pregnancy
Clinical narrative: Case number PHHY2013US116691 is an initial spontaneous report from consumer via Vaccine Adverse Event Reporting System (VAERS reference number: 481129) website on 15 Oct 2013. This case refers to 29-year-old female patient. She was vaccinated with influenza vaccine (unknown manufacturer, batch number: not reported, so conservatively coded as Seasonal Influenza vaccine INN), TDAP (batch number: not reported, other manufacturer) and VARIVAX (batch number: not reported, other manufacturer) on 25 Sep 2012. The patient received these 3 vaccines while she was pregnant. At the time when he received these vaccines she did not know that she was pregnant, but later found out that she was 2 months pregnant. No lab diagnostic study was performed. The patient spoke to her physician. The event outcome was not reported.
Age: 52.0
Sex: F
Vaccine: FLUX, PPV
Symptoms: Injection site swelling, Pyrexia
Clinical narrative: Case number PHHY2013US116701 is an initial spontaneous report from health care professional via Vaccine Adverse Event Reporting System (VAERS reference number: 481166) website on 15 Oct 2013. This case refers to 52-year-old female patient. She was vaccinated with Influenza vaccine (unknown manufacturer, batch number: not reported, so conservatively coded as Seasonal Influenza vaccine INN) and PNEUMOVAX (batch number: H010515) on 26 Sep 2012. On an unspecified date, after the vaccinations, the patient developed swelling at the injection site and a fever of 102 F (Fahrenheit), which was not controlled by ADVIL at home. She was evaluated at an Emergency room and was treated for the swelling. The outcome of events was not reported. The seriousness and causality of events was not reported.
Age: 5.0
Sex: M
Vaccine: DTAPIPV, FLUX, VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Case number PHHY2013US117426 is an initial report received from vaccine adverse event reporting system (VAERS reference number: 481200). This report refers to a 5-year-old male patient. Medical history or concurrent conditions of the patient were not reported. He was vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported), KINRIX and Measles, mumps and rubella vaccine (other manufacturer) all intramuscularly to left arm on 10 Jan 2013. On the same day patient also received VARIVAX (batch number: H011962) intramuscularly to right arm. One day after vaccination (11 Jan 2013), the patient experienced redness, swelling and warmth to site of injection 3x4cm in size. Outcome of the event was reported as condition unchanged as of 14 Jan 2013. Seriousness and causality were not reported.
Age: 13.0
Sex: M
Vaccine: FLUX, HPV4
Symptoms: Lymphadenopathy
Clinical narrative: Case number PHHY2013US117429 is an initial report received from vaccine adverse event reporting system (VAERS reference number: 481240). This report refers to a 13-year-old male patient. Medical history or concurrent conditions of the patient were not reported. He was vaccinated with seasonal Influenza vaccine (manufacturer and batch number: not reported) and GARDASIL (Other manufacturer) to left arm on an unspecified date. The patient developed left axillary adenopathy 3 days following immunization with GARDASIL into left deltoid. Patient visited emergency room due to the event. Outcome of the event was reported as condition unchanged as of 14 Jan 2013. Seriousness and causality were not reported.
Age: 7.0
Sex: M
Vaccine: FLUX
Symptoms: Urticaria
Clinical narrative: Case number PHHY2013US117434 is an initial received from vaccine adverse event reporting system (VAERS reference number: 481281). This report refers to a 07-year-old male patient. Medical history or concurrent conditions of the patient were not reported. He was vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) on 11 Jan 2013. On 12 Jan 2013 (1 day after vaccination) he developed hives for 3 days. It was reported as the reaction come and go. Outcome of the event was reported as condition unchanged as of 14 Jan 2013. Seriousness and causality were not reported.